Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Feb;91(2):397–401. doi: 10.1172/JCI116213

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

H Dieplinger 1, C Lackner 1, F Kronenberg 1, C Sandholzer 1, K Lhotta 1, F Hoppichler 1, H Graf 1, P König 1
PMCID: PMC287937  PMID: 8432847

Abstract

Patients with terminal renal insufficiency suffer from an increased incidence of atherosclerotic diseases. Elevated plasma concentrations of lipoprotein(a) [Lp(a)] have been established as a genetically controlled risk factor for these diseases. Variable alleles at the apo(a) gene locus determine to a large extent the Lp(a) concentration in the general population. In addition, other genetic and nongenetic factors also contribute to the plasma concentrations of Lp(a). We therefore investigated Apo(a) phenotypes and Lp(a) plasma concentrations in a large group of patients with end-stage renal disease (ESRD) and in a control group. Lp(a) concentrations were significantly elevated in ESRD patients (20.1 +/- 20.3 mg/dl) as compared with the controls (12.1 +/- 15.5 mg/dl, P < 0.001). However, no difference was found in apo(a) isoform frequency between the ESRD group and the controls. Interestingly, only patients with large size apo(a) isoforms exhibited two- to fourfold elevated levels of Lp(a), whereas the small-size isoforms had similar concentrations in ESRD patients and controls. Beside elevated Lp(a) concentrations, ESRD patients had lower levels of plasma cholesterol and apolipoprotein B. These results show that elevated Lp(a) plasma levels might significantly contribute to the risk for atherosclerotic diseases in ESRD. They further indicate that nongenetic factors related to renal insufficiency or other genes beside the apo(a) structural gene locus must be responsible for the high Lp(a) levels.

Full text

PDF
397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Hazzard W. R. Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids. 1974 Jan;9(1):15–26. doi: 10.1007/BF02533209. [DOI] [PubMed] [Google Scholar]
  2. Appel G. B., Blum C. B., Chien S., Kunis C. L., Appel A. S. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med. 1985 Jun 13;312(24):1544–1548. doi: 10.1056/NEJM198506133122404. [DOI] [PubMed] [Google Scholar]
  3. Armstrong V. W., Cremer P., Eberle E., Manke A., Schulze F., Wieland H., Kreuzer H., Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis. 1986 Dec;62(3):249–257. doi: 10.1016/0021-9150(86)90099-7. [DOI] [PubMed] [Google Scholar]
  4. Armstrong V. W., Harrach B., Robenek H., Helmhold M., Walli A. K., Seidel D. Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res. 1990 Mar;31(3):429–441. [PubMed] [Google Scholar]
  5. Bagdade J. D., Porte D., Jr, Bierman E. L. Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med. 1968 Jul 25;279(4):181–185. doi: 10.1056/NEJM196807252790403. [DOI] [PubMed] [Google Scholar]
  6. Boerwinkle E., Menzel H. J., Kraft H. G., Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet. 1989 Apr;82(1):73–78. doi: 10.1007/BF00288277. [DOI] [PubMed] [Google Scholar]
  7. Dahlen G. H., Guyton J. R., Attar M., Farmer J. A., Kautz J. A., Gotto A. M., Jr Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986 Oct;74(4):758–765. doi: 10.1161/01.cir.74.4.758. [DOI] [PubMed] [Google Scholar]
  8. Dieplinger H., Lobentanz E. M., König P., Graf H., Sandholzer C., Matthys E., Rosseneu M., Utermann G. Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease. Eur J Clin Invest. 1992 Mar;22(3):166–174. doi: 10.1111/j.1365-2362.1992.tb01822.x. [DOI] [PubMed] [Google Scholar]
  9. Dieplinger H., Schoenfeld P. Y., Fielding C. J. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest. 1986 Apr;77(4):1071–1083. doi: 10.1172/JCI112406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hofmann S. L., Eaton D. L., Brown M. S., McConathy W. J., Goldstein J. L., Hammer R. E. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest. 1990 May;85(5):1542–1547. doi: 10.1172/JCI114602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kamboh M. I., Ferrell R. E., Kottke B. A. Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet. 1991 Nov;49(5):1063–1074. [PMC free article] [PubMed] [Google Scholar]
  12. Karádi I., Romics L., Pálos G., Domán J., Kaszás I., Hesz A., Kostner G. M. Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem. 1989 Oct;35(10):2121–2123. [PubMed] [Google Scholar]
  13. Kostner G. M., Avogaro P., Cazzolato G., Marth E., Bittolo-Bon G., Qunici G. B. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis. 1981 Jan-Feb;38(1-2):51–61. doi: 10.1016/0021-9150(81)90103-9. [DOI] [PubMed] [Google Scholar]
  14. Kraft H. G., Dieplinger H., Hoye E., Utermann G. Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis. 1988 May-Jun;8(3):212–216. doi: 10.1161/01.atv.8.3.212. [DOI] [PubMed] [Google Scholar]
  15. Kraft H. G., Menzel H. J., Hoppichler F., Vogel W., Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest. 1989 Jan;83(1):137–142. doi: 10.1172/JCI113849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Krempler F., Kostner G. M., Roscher A., Haslauer F., Bolzano K., Sandhofer F. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest. 1983 May;71(5):1431–1441. doi: 10.1172/JCI110896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lackner C., Boerwinkle E., Leffert C. C., Rahmig T., Hobbs H. H. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991 Jun;87(6):2153–2161. doi: 10.1172/JCI115248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lindahl G., Gersdorf E., Menzel H. J., Seed M., Humphries S., Utermann G. Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene. Hum Genet. 1990 May;84(6):563–567. doi: 10.1007/BF00210810. [DOI] [PubMed] [Google Scholar]
  19. Lindner A., Charra B., Sherrard D. J., Scribner B. H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974 Mar 28;290(13):697–701. doi: 10.1056/NEJM197403282901301. [DOI] [PubMed] [Google Scholar]
  20. Maeda S., Abe A., Seishima M., Makino K., Noma A., Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 1989 Aug;78(2-3):145–150. doi: 10.1016/0021-9150(89)90218-9. [DOI] [PubMed] [Google Scholar]
  21. Menzel H. J., Dieplinger H., Lackner C., Hoppichler F., Lloyd J. K., Muller D. R., Labeur C., Talmud P. J., Utermann G. Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem. 1990 Jan 15;265(2):981–986. [PubMed] [Google Scholar]
  22. Neville D. M., Jr Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem. 1971 Oct 25;246(20):6328–6334. [PubMed] [Google Scholar]
  23. Parra H. J., Mezdour H., Cachera C., Dracon M., Tacquet A., Fruchart J. C. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem. 1987 May;33(5):721–721. [PubMed] [Google Scholar]
  24. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ. 1990 Dec 1;301(6763):1248–1251. doi: 10.1136/bmj.301.6763.1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sandholzer C., Boerwinkle E., Saha N., Tong M. C., Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 1992 Mar;89(3):1040–1046. doi: 10.1172/JCI115645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Takegoshi T., Haba T., Hirai J., Kitoh C., Saga T., Yamazaki Y., Mabuchi H. Alterations of lipoprotein(a) in patients with diabetic nephropathy. Atherosclerosis. 1990 Jul;83(1):99–100. doi: 10.1016/0021-9150(90)90135-6. [DOI] [PubMed] [Google Scholar]
  27. Utermann G., Hoppichler F., Dieplinger H., Seed M., Thompson G., Boerwinkle E. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4171–4174. doi: 10.1073/pnas.86.11.4171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Utermann G., Menzel H. J., Kraft H. G., Duba H. C., Kemmler H. G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987 Aug;80(2):458–465. doi: 10.1172/JCI113093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Utermann G. The mysteries of lipoprotein(a). Science. 1989 Nov 17;246(4932):904–910. doi: 10.1126/science.2530631. [DOI] [PubMed] [Google Scholar]
  30. Zechner R., Desoye G., Schweditsch M. O., Pfeiffer K. P., Kostner G. M. Fluctuations of plasma lipoprotein-A concentrations during pregnancy and post partum. Metabolism. 1986 Apr;35(4):333–336. doi: 10.1016/0026-0495(86)90150-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES